Psycheceutical Bioscience Inc (OTCMKTS:BWVI) Stock In Focus After Recent News
One of the companies that could be tracked this morning by investors is Psycheceutical Bioscience Inc (OTCMKTS:BWVI) owing to the significant news yesterday. The company is involved in the development of advanced technologies which are meant for advancing mental health treatments.
Trading Data
On Tuesday, BWVI stock fell 1.58% to $0.1807 with more than 4K shares traded, compared to a volume of 34K shares. The stock moved within a range of $0.1800 – 0.1944 after opening trading at $0.1944.
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director
Yesterday Psycheceutical Bioscience was in the news after it announced that it had appointed a new scientific director in the form of Dr. Aric Logsdon. It was a major new appointment from the company and one that could have a major impact in the long term. It now remains to be seen if Psycheceutical Bioscience comes into focus among investors today or not.
In this scenario, it could be a good move to take a look at Dr. Logsdon’s credentials as a professional before making any move on the stock. He is a highly experienced medical professional and is going to be responsible for the drug development efforts at Psycheceutical Bioscience.
He is also going to help the company with advanced biomedical research that would help with product development at Psycheceutical Bioscience. Additionally, he would also be responsible for the advancement of the clinical trial pipeline at Psycheceutical Bioscience.
Key Quote
“As a medical community, we remain largely without treatments for neuropsychiatric and neurocognitive disorders, including post-traumatic stress disorder and dementia. Psychedelics have profound effects on the human brain – which are still poorly understood,” said Dr. Aric Logsdon, Scientific Director of Psycheceutical. “I am proud to join a company with a mission to determine how psychedelics can directly impact the human brain, and I look forward to working with Psycheceutical’s other neuroscience and pharmaceutical development experts towards our goal of making these life-changing treatments more safe and accessible through Psycheceutical.”
Technical Data
BWVI stock is trading below the 20-Day and 50-Day Moving averages of $0.19 and $0.19 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.23.
